Abstract
Trichoscopy has limited value in diagnosing telogen effluvium. Frequent, but not specific, findings include the presence of empty hair follicles, a predominance of follicular units with only one hair, perifollicular discoloration (the peripilar sign), and upright regrowing hairs. There is no significant difference between the findings in the frontal area and those of the occipital area, which differentiates telogen effluvium from androgenetic alopecia. However, clinicians should be aware of the frequent coexistence of both diseases.
Access provided by Autonomous University of Puebla. Download chapter PDF
Similar content being viewed by others
Keywords
- Androgenetic alopecia
- Chronic telogen effluvium
- Follicular units
- Hair shaft thickness heterogeneity
- Perifollicular discoloration
- Peripilar sign
- Telogen effluvium
- Upright regrowing hairs
- Yellow dots
The term telogen effluvium, introduced by Kligman in 1961 [1], refers to a wide range of clinical situations with the common feature of abrupt generalized shedding of telogen hairs. This peculiar type of hair loss is considered very frequent in clinical practice, but very little evidence-based knowledge is available. Two large trichology books, one by Blume-Peytavi et al. [2] and the other by Camacho and Montagna [3], devote only a few pages to telogen effluvium, reflecting the deficit in scientific information about this condition.
Available data indicate that telogen effluvium may be triggered by internal or external factors that cause a large number of hairs to enter the telogen phase at one time. These telogen hairs start shedding about 3–4 months after exposure to the triggering factor. These factors include acute febrile illness, major surgery, psychological trauma, pregnancy, thyroid diseases, discontinuation of estrogen-containing medications, crash diets, iron deficiency, medications (beta-blockers, anticoagulants, retinoids, propylthiouracil, carbamazepine, vaccines), allergic contact dermatitis, and ultraviolet exposure [4–11].
In 1996, Whiting [12] characterized the chronic form of telogen effluvium as a separate entity. Chronic telogen effluvium may represent a primary disorder or may be secondary to a variety of systemic abnormalities, including malabsorption, chronic dietary deficiencies, chronic thyroid diseases, chronic renal or liver failure, systemic lupus erythematosus, and HIV infection [4]. Of all these potential triggers, only chronic iron deficiency has been studied in detail and has had conflicting results [4].
Clinically, chronic telogen effluvium is characterized by a diffuse loss of telogen hairs involving the whole scalp and continuing for more than 6–8 months. Patients report persistent and severe hair shedding that tends to have a fluctuating course for many years. Hair loss may be associated with progressive hair thinning, which uniformly affects all the scalp hairs. Marked bitemporal recession may be present [11, 13, 14].
Although telogen effluvium most commonly affects postmenopausal women, 21 % of patients with this condition are premenopausal women and 11 % are men [15].
The most accurate diagnostic aids for acute and chronic telogen effluvium are histopathology and trichogram in combination with a detailed medical evaluation to identify the cause of telogen hair loss [16].
Trichoscopy has limited value in diagnosing telogen effluvium. Frequent, but not specific, findings include the presence of empty hair follicles, a predominance of follicular units with only one hair, perifollicular discoloration (the peripilar sign), and upright regrowing hairs. There is no significant difference between the findings in the frontal area and those in the occipital area, which differentiates telogen effluvium from androgenetic alopecia. However, clinicians should be aware that both diseases frequently coexist.
References
Kligman AM. Pathologic dynamics of human hair loss. I. Telogen effuvium. Arch Dermatol. 1961;83:175–98.
Blume-Peytavi U, Tosti A, Whiting DA, Trüeb RM, editors. Hair growth and disorders. Berlin/Heidelberg: Springer; 2008.
Camacho F, Montagna W, editors. Trichology: diseases of pilosebaceous follicle. Madrid: Aula Medica Group; 1997.
Trueb RM. Systematic approach to hair loss in women. J Dtsch Dermatol Ges. 2010;8(4):284–97, 98.
Mounsey AL, Reed SW. Diagnosing and treating hair loss. Am Fam Physician. 2009;80(4):356–62.
Durusoy C, Ozenli Y, Adiguzel A, Budakoglu IY, Tugal O, Arikan S, et al. The role of psychological factors and serum zinc, folate and vitamin B12 levels in the aetiology of trichodynia: a case-control study. Clin Exp Dermatol. 2009;34(7):789–92.
Katz KA, Cotsarelis G, Gupta R, Seykora JT. Telogen effluvium associated with the dopamine agonist pramipexole in a 55-year-old woman with Parkinson’s disease. J Am Acad Dermatol. 2006;55(5 Suppl):S103–4.
Patrizi A, Savoia F, Negosanti F, Posar A, Santucci M, Neri I. Telogen effluvium caused by magnesium valproate and lamotrigine. Acta Derm Venereol. 2005;85(1):77–8.
Piraccini BM, Iorizzo M, Rech G, Tosti A. Drug-induced hair disorders. Curr Drug Saf. 2006;1(3):301–5.
Tosti A, Piraccini BM, van Neste DJ. Telogen effluvium after allergic contact dermatitis of the scalp. Arch Dermatol. 2001;137(2):187–90.
Harrison S, Sinclair R. Telogen effluvium. Clin Exp Dermatol. 2002;27(5):389–95.
Whiting DA. Chronic telogen effluvium. Dermatol Clin. 1996;14(4):723–31.
Chen W, Yang CC, Todorova A, Al Khuzaei S, Chiu HC, Worret WI, et al. Hair loss in elderly women. Eur J Dermatol. 2010;20(2):145–51.
Rakowska A, Slowinska M, Kowalska-Oledzka E, Olszewska M, Rudnicka L. Dermoscopy in female androgenic alopecia: method standardization and diagnostic criteria. Int J Trichol. 2009;1(2):123–30.
Garcia-Hernandez MJ, Camacho FM. Chronic telogen effluvium: incidence, clinical and biochemical features, and treatment. Arch Dermatol. 1999;135(9):1123–4.
Olszewska M, Warszawik O, Rakowska A, Slowinska M, Rudnicka L. Methods of hair loss evaluation in patients with endocrine disorders. Endokrynol Pol. 2010;61(4):406–11.
Rakowska A. Trichoscopy (hair and scalp videodermoscopy) in the healthy female. Method standardization and norms for measurable parameters. J Dermatol Case Rep. 2009;3(1):14–9.
Slowinska M. The value of videodermoscopy in differential diagnosis of androgenetic alopecia [doctoral thesis]. Warsaw: Medical University of Warsaw; 2010.
Deloche C, de Lacharriere O, Misciali C, Piraccini BM, Vincenzi C, Bastien P, et al. Histological features of peripilar signs associated with androgenetic alopecia. Arch Dermatol Res. 2004;295(10):422–8.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag London
About this chapter
Cite this chapter
Rakowska, A., Olszewska, M., Rudnicka, L. (2012). Telogen Effluvium. In: Rudnicka, L., Olszewska, M., Rakowska, A. (eds) Atlas of Trichoscopy. Springer, London. https://doi.org/10.1007/978-1-4471-4486-1_18
Download citation
DOI: https://doi.org/10.1007/978-1-4471-4486-1_18
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-4471-4485-4
Online ISBN: 978-1-4471-4486-1
eBook Packages: MedicineMedicine (R0)